Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis

Molecular Microbiology

Volumn 71, Issue 5, 2009, Pages 1263-1277

  Alahari, Anuradha ^a,b   Alibaud, Laeticia ^b   Trivelli, Xavier ^c   Gupta, Radhika ^d   Lamichhane, Gyanu ^d   Reynolds, Robert C ^e   Bishai, William R ^d   Guerardel, Yann ^c   Kremer, Laurent ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG CHAIN FATTY ACID; METHYLTRANSFERASE; MYCOLIC ACID METHYLTRANSFERASE; PROTEIN ETHA; PROTEIN MMAA4; THIOACETAZONE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; DRUG ACTIVATION; GENETIC COMPLEMENTATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; METHYLATION; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; OXIDOREDUCTASES; THIOACETAZONE;

MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 60649090254     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2009.06604.x     Document Type: Article

References (40)

1. Alahari, A., Trivelli, X., Guerardel, Y., Dover, L.G., Besra, G.S., Sacchettini, J.C., et al. (2007) Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS ONE 2 : e1343.
2. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 : 227 230.
3. Bashiri, G., Squire, C.J., Moreland, N.J. Baker, E.N. (2008) Crystal structures of an F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-TB drug candidate PA-824 reveal the basis of coenzyme and substrate binding. J Biol Chem 283 : 17531 17541.
4. Baulard, A.R., Betts, J.C., Engohang-Ndong, J., Quan, S., McAdam, R.A., Brennan, P.J., et al. (2000) Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem 275 : 28326 28331.
5. Behr, M.A., Schroeder, B.G., Brinkman, J.N., Slayden, R.A. Barry, C.E., 3rd (2000) A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol 182 : 3394 3399.
6. Bermudez, L.E., Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C.B. Young, L.S. (2003) Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. Antimicrob Agents Chemother 47 : 2685 2687.
7. Boissier, F., Bardou, F., Guillet, V., Uttenweiler-Joseph, S., Daffe, M., Quemard, A. Mourey, L. (2006) Further insight into S-adenosylmethionine- dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. J Biol Chem 281 : 4434 4445.
8. Brennan, P.J. Nikaido, H. (1995) The envelope of mycobacteria. Annu Rev Biochem 64 : 29 63.
9. Cole, S.T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 : 537 544.
10. Daffe, M. Draper, P. (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39 : 131 203.
11. Dao, D.N., Sweeney, K., Hsu, T., Gurcha, S.S., Nascimento, I.P., Roshevsky, D., et al. (2008) Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4 : e1000081.
12. Davidson, P.T. Le, H.Q. (1992) Drug treatment of tuberculosis - 1992. Drugs 43 : 651 673.
13. DeBarber, A.E., Mdluli, K., Bosman, M., Bekker, L.G. Barry, C.E., 3rd (2000) Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 97 : 9677 9682.
14. Dinadayala, P., Laval, F., Raynaud, C., Lemassu, A., Laneelle, M.A., Laneelle, G. Daffe, M. (2003) Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain devoid of methoxy- and ketomycolates. J Biol Chem 278 : 7310 7319.
15. Dover, L.G., Alahari, A., Gratraud, P., Gomes, J.M., Bhowruth, V., Reynolds, R.C., et al. (2007) EthA, a common activator of thiocarbamide- containing drugs acting on different mycobacterial targets. Antimicrob Agents Chemother 51 : 1055 1063.
16. Dubnau, E., Chan, J., Raynaud, C., Mohan, V.P., Laneelle, M.A., Yu, K., et al. (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36 : 630 637.
17. Glickman, M.S. (2003) The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid. J Biol Chem 278 : 7844 7849.
18. Glickman, M.S., Cox, J.S. Jacobs, W.R., Jr. (2000) A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 5 : 717 727.
19. Huang, C.C., Smith, C.V., Glickman, M.S., Jacobs, W.R., Jr, Sacchettini, J.C. (2002) Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis. J Biol Chem 277 : 11559 11569.
20. Kremer, L., Baulard, A.R. Besra, G.S. (2000) Genetics of mycolic acid biosynthesis. In Molecular Genetics of Mycobacteria. Hatfull, G.F. Jacobs, W.R., Jr (eds). Washington, DC : American Society for Microbiology Press, pp. 173 190.
21. Kremer, L., Guerardel, Y., Gurcha, S.S., Locht, C. Besra, G.S. (2002) Temperature-induced changes in the cell-wall components of Mycobacterium thermoresistibile. Microbiology 148 : 3145 3154.
22. Lamichhane, G., Zignol, M., Blades, N.J., Geiman, D.E., Dougherty, A., Grosset, J., et al. (2003) A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 100 : 7213 7218.
23. Laval, F., Laneelle, M.A., Deon, C., Monsarrat, B. Daffe, M. (2001) Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry. Anal Chem 73 : 4537 4544.
24. Manjunatha, U.H., Boshoff, H., Dowd, C.S., Zhang, L., Albert, T.J., Norton, J.E., et al. (2006) Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 103 : 431 436.
25. Minnikin, D.E., Minnikin, S.M., Dobson, G., Goodfellow, M., Portaels, F., van den Breen, L. Sesardic, D. (1983) Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol 129 : 889 891.
26. Nunn, P., Porter, J. Winstanley, P. (1993) Thiacetazone - avoid like poison or use with care? Trans R Soc Trop Med Hyg 87 : 578 582.
27. Rachman, H., Strong, M., Ulrichs, T., Grode, L., Schuchhardt, J., Mollenkopf, H., et al. (2006) Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect Immun 74 : 1233 1242.
28. Rao, V., Fujiwara, N., Porcelli, S.A. Glickman, M.S. (2005) Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201 : 535 543.
29. Rao, V., Gao, F., Chen, B., Jacobs, W.R., Jr, Glickman, M.S. (2006) Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116 : 1660 1667.
30. Scorpio, A. Zhang, Y. (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2 : 662 667.
31. Stover, C.K., de la Cruz, V.F., Fuerst, T.R., Burlein, J.E., Benson, L.A., Bennett, L.T., et al. (1991) New use of BCG for recombinant vaccines. Nature 351 : 456 460.
32. Stover, C.K., Warrener, P., VanDevanter, D.R., Sherman, D.R., Arain, T.M., Langhorne, M.H., et al. (2000) A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405 : 962 966.
33. Takayama, K., Wang, C. Besra, G.S. (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18 : 81 101.
34. Vilcheze, C., Wang, F., Arai, M., Hazbon, M.H., Colangeli, R., Kremer, L., et al. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12 : 1027 1029.
35. Vilcheze, C., Av-Gay, Y., Attarian, R., Liu, Z., Hazbon, M.H., Colangeli, R., et al. (2008) Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol 69 : 1316 1329.
36. Wang, F., Langley, R., Gulten, G., Dover, L.G., Besra, G.S., Jacobs, W.R., Jr. Sacchettini, J.C. (2007) Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 204 : 73 78.
37. Yuan, Y. Barry, C.E., 3rd (1996) A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 93 : 12828 12833.
38. Yuan, Y., Zhu, Y., Crane, D.D. Barry, C.E., 3rd (1998) The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol 29 : 1449 1458.
39. Zhang, Y., Heym, B., Allen, B., Young, D. Cole, S. (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358 : 591 593.
40. Zhang, Y., Garbe, T. Young, D. (1993) Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 8 : 521 524.